Dr. Brendan Carvalho shares insights from a study comparing Accuro’s accuracy to other ultrasound devices for neuraxial anesthesia. He explains how both Accuro and larger ultrasound systems reliably predict the point of loss of resistance, particularly in patients with challenging anatomy, such as those with obesity, scoliosis, or previous spine surgery. Dr. Carvalho highlights Accuro’s key advantages, including its portability, 3D navigation, and unique skin-marking feature, which together enhance precision and usability in both clinical and teaching environments.
Recent Posts
- A 40% Obesity Rate Demands Precision Neuraxial Anesthesia
- BARDA awards nearly $10 million to RIVANNA to accelerate development of CADe/x AI module for Accuro XV
- RIVANNA’s next-generation ultrasound guidance platform and AI-driven imaging software receive FDA 510(K) clearance
- Building a Health System to Support Aging Populations [6 Steps]
- Some Studies Show Up to 25% Fewer Assisted Deliveries With Low-Dose Epidurals